miDiagnostics
miDiagnostics is developing a comprehensive menu of syndromic tests for screening, diagnosis and monitoring of a wide range of health conditions.
$34.88M Series B+ ·
Led by Thermo Fisher Scientific · Source: startupintros.com
Funding history ↓Signals
Website registeredJul 17, 2014 (12 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $34.88M | startupintros.com |
Timeline
- Website created
Founders and team
NV
Nicolas Vergauwe FounderDM
David Morrow Senior VP Engineering & Product DevelopmentKV
Katleen Verleysen Chief Executive Officer
Investors
AAlychlo
EEuropean Investment Bank Group
PPamica AB
RRudi Pauwels
TThermo Fisher Scientificlead investor
- UUrbain Vandeurzen
- VVMF Invest
Companies like miDiagnostics
BBiolinq$100M Series B+ · Apr 2025
IInocras$31M Series B+ · Aug 2026
VVillanelle LifeSeed · Jul 2026
TTalkiatry$210M Series B+ · Feb 2026
AArcheon Medical$9M Series A · Oct 2026
LLinusBio$16M Series A · Jan 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/midiagnostics (get a free API key).